Longevity Health Holdings Inc

Longevity Health Holdings Inc (XAGE) Stock Analysis

$2.320

-0.356 (-15.33%)At close

Loading chart…
High
2.799
Open
2.720
VWAP
2.47
Vol
249.03K
Mkt Cap
—
Low
2.280
Amount
614.23K
EV/EBITDA, TTM
0.00

Longevity Health Holdings, Inc. is focused on longevity and healthy aging, encompassing the latest scientific advances in regenerative bio-aesthetics. The Company has two cosmetic product lines, Carmell Secretomeand and Elevai Exosomes, that support skin and hair health. All of its cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. The Carmell Secretome consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. The Carmell Secretome product portfolio and pipeline includes Face and Neck Collection (Retail), ProSynergy Collection (Doctors/Medspas), and others. The Elevai Exosomes are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Elevai Exosomes skincare products include Elevai Empower and Elevai Enfinity.

www.carmellcosmetics.com

Valuation Metrics

The current forward P/E ratio for Longevity Health Holdings Inc (XAGE) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Overvalued
0.00
Undervalued
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Overvalued
0.00
Undervalued
0.00

Alphio AI Price Scenarios for XAGE

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%XAGE

$4.54

Scenario price

B

Base

Base · 50%XAGE

$4.38

Scenario price

B

Bear

Bear · 25%XAGE

$3.92

Scenario price

Events Timeline

2026-03-17 (ET)

08:50:00

Longevity Health Appoints Ram Ajjarapu as Chairman and CEO

2025-07-14 (ET)

16:40:10

Longevity Health, True Health to combine in all-stock transaction

2025-05-27 (ET)

09:22:10

Longevity Health extends cash runway into 1Q26

2025-05-21 (ET)

16:39:24

Longevity announces continued Nasdaq listing to complete 20/20 BioLabs deal

2025-05-15 (ET)

08:12:46

Longevity Health reports unaudited Q1 revenue $663,000, up 8% year-over-year

Show More Events

News

Show More News

XAGE FAQ — answered by Alphio AI

Longevity Health Holdings, Inc. is focused on longevity and healthy aging, encompassing the latest scientific advances in regenerative bio-aesthetics. The Company has two cosmetic product lines, Carmell Secretomeand and Elevai Exosomes, that support skin and hair health. All of its cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. The Carmell Secretome consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. The Carmell Secretome product portfolio and pipeline includes Face and Neck Collection (Retail), ProSynergy Collection (Doctors/Medspas), and others. The Elevai Exosomes are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Elevai Exosomes skincare products include Elevai Empower and Elevai Enfinity. It operates in the Healthcare sector.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started